secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2026-08-13T20:13:36+00:00
Accession:  0001753926-26-001479
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q2 revenue down 68.5% to $2.3M; net loss $8.7M
----------------------------------------------------------------

- Revenue $2.3M vs $7.3M in Q2 2025; 11 units sold vs 19, with 8 units deferred to Q3 on financing timing.
- Net loss $8.7M ($0.53/share) vs $1.0M ($0.06/share); includes $5.7M valuation allowance on deferred tax assets.
- Adjusted EBITDA negative $3.0M vs negative $1.8M; gross margin 34.8% vs 39.7% on product mix.
- CMS proposed 26% increase in hospital-based SRT delivery code, if finalized would improve provider economics.
- Management cites strong pipeline, expanded Asia-Pacific activity (Australia, New Zealand); expects strong H2 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000175392626001479/0001753926-26-001479-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000175392626001479/g085863_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-26-001479

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer